Marco Turconi

526 total citations
22 papers, 404 citations indexed

About

Marco Turconi is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marco Turconi has authored 22 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marco Turconi's work include Receptor Mechanisms and Signaling (8 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Nausea and vomiting management (2 papers). Marco Turconi is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Nausea and vomiting management (2 papers). Marco Turconi collaborates with scholars based in Italy, France and United States. Marco Turconi's co-authors include A. Donetti, H. Ladinsky, E. Giraldo, Massimo Di Nicola, C.A. Rizzi, P Schiantarelli, R. Micheletti, Eugenia Monferini, Aline Dumuis and Franco Borsini and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and British Journal of Pharmacology.

In The Last Decade

Marco Turconi

21 papers receiving 342 citations

Peers

Marco Turconi
Ralph A. Lessor United States
D. Malcolm Duckworth United Kingdom
Steven Dabbs United States
Akira Horita United States
Norbert L. Wiech United States
Susan L. Mercer United States
M. Hooper United Kingdom
Laura A. Wittenauer United States
Peter Blurton United Kingdom
Marco Turconi
Citations per year, relative to Marco Turconi Marco Turconi (= 1×) peers A. Donetti

Countries citing papers authored by Marco Turconi

Since Specialization
Citations

This map shows the geographic impact of Marco Turconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Turconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Turconi more than expected).

Fields of papers citing papers by Marco Turconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Turconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Turconi. The network helps show where Marco Turconi may publish in the future.

Co-authorship network of co-authors of Marco Turconi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Turconi. A scholar is included among the top collaborators of Marco Turconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Turconi. Marco Turconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmisano, Giovanni, et al.. (2005). Statistical experimental design-driven discovery of room-temperature conditions for palladium-catalyzed cyanation of aryl bromides. Tetrahedron Letters. 46(11). 1815–1818. 21 indexed citations
3.
Borsini, Franco, A. Brambilla, Angelo Ceci, et al.. (1998). Flibanserin < Prop INN >. Drugs of the Future. 23(1). 9–9. 11 indexed citations
5.
Turconi, Marco, et al.. (1994). Synthesis of SubstitutedN-Arylpiperidines via Organobismuth Derivatives. Synthesis. 1994(8). 775–776. 14 indexed citations
6.
Meel, J. C. A. van, R. Haigh, Wolfgang Wienen, et al.. (1993). The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs. European Journal of Pharmacology. 233(2-3). 295–297. 8 indexed citations
7.
Schiavi, G.B., Lucilla D. Monti, Klaus Mendla, et al.. (1993). Distribution of the muscarinic receptor subtypes in rat olfactory bulb as determined with three selective second generation antagonists DAU 6202, AQ-RA 741 and DAG 5600. Life Sciences. 52(5-6). 572–572. 2 indexed citations
8.
Cosentino, Ugo, Giorgio Moro, E. Giraldo, et al.. (1993). The role of electronic and conformational properties in the activity of 5-HT3 receptor antagonists. Journal of Molecular Structure THEOCHEM. 286. 275–291. 2 indexed citations
9.
Giraldo, E., et al.. (1992). DAU 6285: A novel antagonist at the putative 5-HT4 receptor. Life Sciences. 51(8). 583–592. 26 indexed citations
10.
Dumuis, Aline, H. Gozlan, Michèle Sebben, et al.. (1992). Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(3). 264–9. 46 indexed citations
11.
Turconi, Marco, A. Sagrada, E. Montagna, et al.. (1991). Pharmacological properties of a novel class of 5-HT3 receptor antagonists. European Journal of Pharmacology. 203(2). 203–211. 22 indexed citations
12.
Sagrada, A., Marco Turconi, P Schiantarelli, et al.. (1991). Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. Cancer Chemotherapy and Pharmacology. 28(6). 470–474. 9 indexed citations
13.
Turconi, Marco, et al.. (1991). Malonamic acid derivatives as M1 selective muscarinic receptor antagonists.. PubMed. 46(9). 999–1009. 1 indexed citations
14.
Dumuis, Aline, Michèle Sebben, Eugenia Monferini, et al.. (1991). Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in braina. Naunyn-Schmiedeberg s Archives of Pharmacology. 343(3). 245–51. 42 indexed citations
15.
Nicola, Massimo Di, et al.. (1991). Synthesis and biological evaluation of new muscarinic receptor antagonists bearing cyclic amidines as cationic heads.. PubMed. 46(4). 539–53.
16.
CAVALLERI, B., Marco Turconi, R Pallanza, et al.. (1990). Synthesis and biological activity of some derivatives of rifamycin P. Journal of Medicinal Chemistry. 33(5). 1470–1476. 18 indexed citations
17.
Turconi, Marco, et al.. (1990). Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists. Journal of Medicinal Chemistry. 33(8). 2101–2108. 51 indexed citations
18.
Micheletti, R., et al.. (1990). 4‐DAMP analogues reveal heterogeneity of M1 muscarinic receptors. British Journal of Pharmacology. 100(3). 395–397. 15 indexed citations
19.
Turconi, Marco, et al.. (1987). Anti-secretory and anti-ulcer activities of some new 2-(2-pyridylmethyl-sulfinyl)-benzimidazoles. European Journal of Medicinal Chemistry. 22(6). 527–537. 32 indexed citations
20.
CAVALLERI, B., Marco Turconi, & ROSETTA PALLANZA. (1985). Synthesis and antibacterial activity of some derivatives of the antibiotic thermorubin.. The Journal of Antibiotics. 38(12). 1752–1760. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026